Welcome to our dedicated page for WW International news (Ticker: WW), a resource for investors and traders seeking the latest updates and insights on WW International stock.
WW International, Inc. (WeightWatchers), trading under the symbol WW, is frequently in the news for developments in science-backed weight management, clinical programs, and digital health innovation. Company announcements emphasize its role as a global leader in weight health, combining behavioral programs, clinical care, GLP‑1 medications when appropriate, and technology-enabled support.
News about WeightWatchers often covers updates to its integrated GLP‑1 platform, including the WeightWatchers Med+ program and the GLP‑1 Success behavioral support experience. Releases have highlighted access to FDA‑approved GLP‑1 treatments, such as an oral formulation of Wegovy, and the company’s positioning as a NovoCare Recognized Care Provider. These stories focus on how WeightWatchers pairs medication access with evidence‑based nutrition, coaching, and community to improve outcomes.
Investors and observers will also find coverage of new product and feature launches within the WeightWatchers app, such as the Weight Health Score, AI Body Scanner, fitness content partnerships, and configurable Modes that adjust support as members move from weight loss to maintenance. Additional news items include the launch of specialized programs like WeightWatchers for Menopause, the publication of WeightWatchers for Business annual results, collaborations with partners like Amazon Pharmacy, and the introduction of the WeightWatchers Awards for health and wellness products.
On this news page, readers can track earnings announcements, conference participation, leadership appointments, and strategic initiatives related to WeightWatchers’ transformation in the GLP‑1 era. For those following WW stock or the broader weight health sector, the news feed provides a centralized view of how the company is evolving its behavioral and clinical businesses, expanding partnerships, and refining its global weight management platform.
WW International, Inc. (NASDAQ: WW) announced positive results from a clinical trial presented at the ADA 82nd Scientific Sessions. The trial evaluated its diabetes-specific program for weight management, involving 136 participants with Type 2 diabetes. Key findings include a reduction in HbA1c levels by 0.76, an average weight loss of 5.7%, and decreased diabetes distress by 9.8%. These improvements exceed FDA standards, indicating the program's effectiveness in promoting health among those living with diabetes. The study highlights the relevance of weight management in managing diabetes.
WW International reported Q1 2022 results with revenues of $297.8 million, a 10.3% decline from Q1 2021. The company experienced an 8.3% decrease in subscribers, totaling 4.5 million. Despite revenue declines, Q1 operating income rose to $9.0 million, significantly up from $2.8 million in the previous year, aided by cost management and reduced marketing expenses. The 2022 restructuring plan is projected to save nearly $30 million annually. FY 2022 guidance anticipates revenues of $1.09 billion to $1.14 billion and GAAP EPS between $0.72 and $0.78.
WW International, Inc. (NASDAQ: WW) will announce its first-quarter 2022 financial results on May 5, 2022, after market hours. A conference call will follow at 5:00 p.m. ET, featuring CEO Sima Sistani and CFO Amy O’Keefe discussing the results and answering investor questions. The call will be available via live webcast on WW's corporate website, with a replay accessible for 90 days. The company emphasizes its human-centric wellness approach driven by its weight management program, aiming for holistic wellness across diverse communities.
WW International reported its Q4 and FY 2021 results, highlighting revenues of $276 million in Q4 and $1.2 billion for the year, both down from prior periods. Subscription revenues decreased by 13.5% in Q4 and 10.4% for the year. Gross margin stood at 61.2% for Q4 and improved to 61.2% for FY 2021, despite a drop in operating income to $196 million. Looking ahead, Q1 2022 is expected to generate approximately $300 million in revenues but forecasted a net loss per share of $0.26 to $0.31. Sima Sistani will take over as CEO on March 21, 2022.
On February 25, 2022, WW International, Inc. (NASDAQ: WW) announced the employment inducement equity award for its new CEO, Sima Sistani, starting March 21, 2022. The award includes 1 million nonqualified stock options, split between two exercise prices: $30.00 and $50.00, vesting annually over four years. This inducement aligns with Nasdaq Listing Rule 5635(c)(4) and aims to support Sistani's decision to join the company.
WW International, Inc. (NASDAQ: WTW) has announced the appointment of Sima Sistani as Chief Executive Officer, effective March 21. Sistani, a co-founder of Houseparty and former senior leader at Epic Games, takes over from Mindy Grossman, who will leave the company on March 18. Sistani has over 20 years of experience in media and technology, including notable roles at Yahoo! and Epic Games. The board believes her experience in digital communities and innovation will guide WW in enhancing health and wellness among its global members.
WW International, Inc. (NASDAQ: WW) will announce its financial results for Q4 and the full year 2021 on March 1, 2022, post-market. A conference call will follow at 5:00 p.m. ET, featuring CEO Mindy Grossman, COO Nicholas Hotchkin, and CFO Amy O’Keefe, who will review the results and field questions. The call can be accessed via a live webcast on the company's corporate site. WW focuses on delivering a comprehensive, science-based wellness program through its digital app and expert coaching to inspire healthy living.
WW International, Inc. (NASDAQ: WW) has been recognized as the #1 Best Diet for Weight Loss and Best Diet Program in the 2022 U.S. News & World Report rankings for the twelfth consecutive year. This achievement highlights WW's commitment to scientific expertise and effective weight management.
The company's recent launch of the PersonalPoints™ weight-loss program aims to enhance user experience with individualized plans and tools that promote sustainable weight loss.
Summary not available.
WW International, Inc. (Nasdaq: WW) will present at the BofA Securities 2021 Virtual Leveraged Finance Conference on December 2, 2021, at 10:30 a.m. ET. The presentation will be led by Chief Financial Officer Amy O’Keefe and accessible via live audio webcast on the company's corporate website. An archive will be available for 30 days post-event.
WW is a human-centric technology company focused on wellness, leveraging nearly six decades of expertise in nutritional and behavioral change science to inspire healthy habits globally.